Three new vaccine codes for pediatric patients ages 6 through 11
Topics Related to Bulletins
FDA authorizes Paxlovid for treatment of COVID-19 to be prescribed by pharmacists
Guidance published with examples, training and certification opportunities
Leuprolide Injectable Emulsion, for Subcutaneous Use (Camcevi™) HCPCS Code J1952: Billing Guidelines
Effective April 1, 2022, Medicaid and NC Health Choice cover leuprolide injectable emulsion
Effective April 18, 2022, Medicaid and NC Health Choice cover lanreotide injection
Effective May 15, 2022, technical changes were made to address access to care concerns.
System updates are completed to align our policies with HCPCS code changes
Guidance for NC Medicaid Direct and NC Medicaid Managed Care
Program sunset extended from June 30, 2022 to July 15, 2022
Primary Series for Children Ages 6 Through 11 Years